British Business Bank
BB
BR
British Business Bank
About
Key facts
- Portfolio companies
- 25
- Stages
- Series AVenture Fund
- Cheque size
- $1M to $1.1B
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 14 Oct 2026 | Salience Labs | Series B | $125M |
| 1 Oct 2026 | Microbiotica | Series C | $45M |
| 29 Jul 2026 | Kinematic Trees | Pre-Seed | $747K |
| 13 Jul 2026 | Draig Therapeutics | Series B | $65M |
| 9 Jul 2026 | Kraken | Series B | $175M |
| 1 Jul 2026 | Alchemab Therapeutics | Series A | $32M |
| 3 Jun 2026 | OQC | Series C | $350M |
| 2 Jun 2026 | IMU Biosciences | Series A | $53M |
| 2 Jun 2026 | Oxford Quantum Circuits | Series C | $350M |
| 12 May 2026 | Elliptic | Series D | $120M |
Write the first review
Frequently asked
What companies has British Business Bank invested in?
British Business Bank has invested in Salience Labs, Microbiotica, Kinematic Trees, Draig Therapeutics, Kraken and 20 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for British Business Bank:

